About OhhMed Medical
OhhMed Medical is a clinical-stage medtech company redefining how male urological conditions are treated.
Our patented RF-based platform restores erectile and penile function by stimulating tissue regeneration, improving vascular health, and rebuilding the structural integrity of the tunica albuginea.
We focus on real-world applications, bringing clinically validated, drug-free treatments to men affected by ED, Peyronie’s Disease and post-prostate cancer recovery.
Founder – Daniel Lischinsky
Daniel Lischinsky is a veteran innovator in medical device development, with more than 25 years of experience in RF technologies and semiconductors.
Prior to founding OhhMed Medical, he co-founded Endymed, a successful RF-based aesthetics company operating in over 50 countries.
At OhhMed, Daniel applies his technical expertise and leadership to build the next generation of restorative devices – ones that address the root causes of dysfunction, not just the symptoms.
Under his guidance, OhhMed has developed a full product suite, secured CE approvals, and launched pivotal trials across multiple markets.
CFO – Eli Sayag
Eli brings vast experience in executive finance management and strong finance and operational leadership.
He has 15 years of experience in managing the financial operations of companies including numerous M&A deals.
Eli previously served in senior finance positions in a global Aerospace and Defense public traded company.
He holds an MBA from Tel-Aviv University and a BA in Accounting and Economics from Haifa University. Eli is a Certified Public Accountant in Israel.
Scientific & Clinical Advisory Board
Prof. Ilan Gruenwald
Director of Neuro-Urology, Israel
Prof. David Ralph
Consultant Urologist, UK
Prof. Cobi Reisman
Sexual Medicine Specialist, Netherlands
Prof. Juza Chen
Urologist, Israel